4SC-202 as a potential treatment for the pediatric brain tumor medulloblastoma

Shanta M. Messerli, Mariah M. Hoffman, Etienne Z. Gnimpieba, Hella Kohlhof, Ratan D. Bhardwaj

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This project involves an examination of the effect of the small molecule inhibitor 4SC-202 on the growth of the pediatric brain cancer medulloblastoma. The small molecule inhibitor 4SC-202 significantly inhibits the viability of the pediatric desmoplastic cerebellar human medulloblastoma cell line DAOY, with an IC50 = 58.1 nM, but does not affect the viability of noncancerous neural stem cells (NSC). 4SC-202 exposure inhibits hedgehog expression in the DAOY cell line. Furthermore, microarray analysis of human medulloblastoma patient tumors indicate significant upregulation of key targets in the Hedgehog signaling pathway and Protein Tyrosine Kinase (PTK7).

Original languageEnglish (US)
Article number147
JournalBrain Sciences
Volume7
Issue number11
DOIs
StatePublished - Nov 2017

Fingerprint

Medulloblastoma
Brain Neoplasms
Pediatrics
Cell Line
Neural Stem Cells
Microarray Analysis
Protein-Tyrosine Kinases
Inhibitory Concentration 50
Up-Regulation
Therapeutics
Growth
Neoplasms

Keywords

  • 4SC-202
  • Bioinformatics
  • Medulloblastoma
  • Microarray
  • Pediatric brain tumor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

4SC-202 as a potential treatment for the pediatric brain tumor medulloblastoma. / Messerli, Shanta M.; Hoffman, Mariah M.; Gnimpieba, Etienne Z.; Kohlhof, Hella; Bhardwaj, Ratan D.

In: Brain Sciences, Vol. 7, No. 11, 147, 11.2017.

Research output: Contribution to journalArticle

Messerli, Shanta M. ; Hoffman, Mariah M. ; Gnimpieba, Etienne Z. ; Kohlhof, Hella ; Bhardwaj, Ratan D. / 4SC-202 as a potential treatment for the pediatric brain tumor medulloblastoma. In: Brain Sciences. 2017 ; Vol. 7, No. 11.
@article{a17068202f084fbdaa61ce8ede51ef00,
title = "4SC-202 as a potential treatment for the pediatric brain tumor medulloblastoma",
abstract = "This project involves an examination of the effect of the small molecule inhibitor 4SC-202 on the growth of the pediatric brain cancer medulloblastoma. The small molecule inhibitor 4SC-202 significantly inhibits the viability of the pediatric desmoplastic cerebellar human medulloblastoma cell line DAOY, with an IC50 = 58.1 nM, but does not affect the viability of noncancerous neural stem cells (NSC). 4SC-202 exposure inhibits hedgehog expression in the DAOY cell line. Furthermore, microarray analysis of human medulloblastoma patient tumors indicate significant upregulation of key targets in the Hedgehog signaling pathway and Protein Tyrosine Kinase (PTK7).",
keywords = "4SC-202, Bioinformatics, Medulloblastoma, Microarray, Pediatric brain tumor",
author = "Messerli, {Shanta M.} and Hoffman, {Mariah M.} and Gnimpieba, {Etienne Z.} and Hella Kohlhof and Bhardwaj, {Ratan D.}",
year = "2017",
month = "11",
doi = "10.3390/brainsci7110147",
language = "English (US)",
volume = "7",
journal = "Brain Sciences",
issn = "2076-3425",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",

}

TY - JOUR

T1 - 4SC-202 as a potential treatment for the pediatric brain tumor medulloblastoma

AU - Messerli, Shanta M.

AU - Hoffman, Mariah M.

AU - Gnimpieba, Etienne Z.

AU - Kohlhof, Hella

AU - Bhardwaj, Ratan D.

PY - 2017/11

Y1 - 2017/11

N2 - This project involves an examination of the effect of the small molecule inhibitor 4SC-202 on the growth of the pediatric brain cancer medulloblastoma. The small molecule inhibitor 4SC-202 significantly inhibits the viability of the pediatric desmoplastic cerebellar human medulloblastoma cell line DAOY, with an IC50 = 58.1 nM, but does not affect the viability of noncancerous neural stem cells (NSC). 4SC-202 exposure inhibits hedgehog expression in the DAOY cell line. Furthermore, microarray analysis of human medulloblastoma patient tumors indicate significant upregulation of key targets in the Hedgehog signaling pathway and Protein Tyrosine Kinase (PTK7).

AB - This project involves an examination of the effect of the small molecule inhibitor 4SC-202 on the growth of the pediatric brain cancer medulloblastoma. The small molecule inhibitor 4SC-202 significantly inhibits the viability of the pediatric desmoplastic cerebellar human medulloblastoma cell line DAOY, with an IC50 = 58.1 nM, but does not affect the viability of noncancerous neural stem cells (NSC). 4SC-202 exposure inhibits hedgehog expression in the DAOY cell line. Furthermore, microarray analysis of human medulloblastoma patient tumors indicate significant upregulation of key targets in the Hedgehog signaling pathway and Protein Tyrosine Kinase (PTK7).

KW - 4SC-202

KW - Bioinformatics

KW - Medulloblastoma

KW - Microarray

KW - Pediatric brain tumor

UR - http://www.scopus.com/inward/record.url?scp=85033481040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033481040&partnerID=8YFLogxK

U2 - 10.3390/brainsci7110147

DO - 10.3390/brainsci7110147

M3 - Article

C2 - 29099739

AN - SCOPUS:85033481040

VL - 7

JO - Brain Sciences

JF - Brain Sciences

SN - 2076-3425

IS - 11

M1 - 147

ER -